ArticleInfectious diseases of poverty2026
Progress and challenges in development of minimum essential dataset for disease surveillance through a One Health lens: a scoping review.
Article in Infectious diseases of poverty, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bridging policy and practice: implementation of emerging infectious disease risk assessment in China from a One Health perspective.Science in One Health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundMinimum essential dataset (MED) enables One Health surveillance by facilitating cross-sectoral data sharing. Yet, existing MED research represents insufficient integration of the One Health concept, and its progress in disease surveillance remains unclear. This study aims to evaluate the current progress and gaps in MED research in disease surveillance through a One Health lens.
methodsThis scoping review systematically searched Embase, PubMed, Scopus, and Web of Science from the inception of databases to November 30th, 2024 to identify studies published in English. Studies were independently screened by two reviewers for inclusion based on their relevance to the development of MEDs for disease surveillance. The progress and challenges were synthesized based on data extracted from eligible studies.
resultsThis review includes 28 eligible studies for analysis, all of which focused on infectious diseases. MED development is predominantly concentrated on the human health interface (89.3%), whereas animal and environmental interfaces are comparatively limited (≤ 10.7%). The One Health concept has been adopted in 16 of the eligible studies; however, there is still insufficient interdisciplinary and cross-sectoral collaboration (57.1%). Meanwhile, numerous methods have been employed in the development of MEDs, with qualitative approaches being the most prevalent (42.9%), while data-driven approaches remain scarce. The absence of a standardized approach is recognized as a primary barrier. Thus, we propose a pathway and operational tool to detail the specific steps, which could facilitate future research on MED.
conclusionThis review highlights critical gaps in MED development at the human-animal-environment interface, and proposes a pathway and operational tool to inform future development of MED, including scope identification, establishment, modification and improvement. This study promotes the improvement of disease surveillance system and provides insights to enhance future preparedness for reducing the global public health burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.